Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Journal of hepatology

Results: 26-50/2952

Authors: van Erpecum, KJ Wang, DQH Lammert, F Paigen, B Groen, AK Carey, MC
Citation: Kj. Van Erpecum et al., Phenotypic characterization of Lith genes that determine susceptibility tocholesterol cholelithiasis in inbred mice: soluble pronucleating proteins in gallbladder and hepatic biles, J HEPATOL, 35(4), 2001, pp. 444-451

Authors: Albornoz, L Motta, A Alvarez, D Estevez, A Bandi, JC McCormack, L Matera, J Bonofiglio, C Ciardullo, M de Santibannes, E Gimeno, M Gadano, A
Citation: L. Albornoz et al., Nitric oxide synthase activity in the splanchnic vasculature of patients with cirrhosis: relationship with hemodynamic disturbances, J HEPATOL, 35(4), 2001, pp. 452-456

Authors: Bruck, R Shirin, H Aeed, H Matas, Z Hochman, A Pines, M Avni, Y
Citation: R. Bruck et al., Prevention of hepatic cirrhosis in rats by hydroxyl radical scavengers, J HEPATOL, 35(4), 2001, pp. 457-464

Authors: Watanabe, T Niioka, M Ishikawa, A Hozawa, S Arai, M Maruyama, K Okada, A Okazaki, I
Citation: T. Watanabe et al., Dynamic change of cells expressing MMP-2 mRNA and MT1-MMP mRNA in the recovery from liver fibrosis in the rat, J HEPATOL, 35(4), 2001, pp. 465-473

Authors: Murata, T Arii, S Nakamura, T Mori, A Kaido, T Furuyama, H Furumoto, K Nakao, T Isobe, N Imamura, M
Citation: T. Murata et al., Inhibitory effect of Y-27632, a ROCK inhibitor, on progression of rat liver fibrosis in association with inactivation of hepatic stellate cells, J HEPATOL, 35(4), 2001, pp. 474-481

Authors: Gardini, G Cabella, C Cravanzola, C Vargiu, C Belliardo, S Testore, G Solinas, SP Toninello, A Grillo, MA Colombatto, S
Citation: G. Gardini et al., Agmatine induces apoptosis in rat hepatocyte cultures, J HEPATOL, 35(4), 2001, pp. 482-489

Authors: Wielockx, B Bussolino, F Shapiro, SD Libert, C
Citation: B. Wielockx et al., Involvement of a serine protease, but not of neutrophil elastase, in tumornecrosis factor-induced lethal hepatitis and induction of platelet-activating factor, J HEPATOL, 35(4), 2001, pp. 490-497

Authors: Fracanzani, AL Taioli, E Sampietro, M Fatta, E Bertelli, C Fiorelli, G Fargion, S
Citation: Al. Fracanzani et al., Liver cancer risk is increased in patients with porphyria cutanea tarda incomparison to matched control patients with chronic liver disease, J HEPATOL, 35(4), 2001, pp. 498-503

Authors: Kagaya, M Kaneko, S Ohno, H Inamura, K Kobayashi, K
Citation: M. Kagaya et al., Cloning and characterization of the 5 '-flanking region of human cytokeratin 19 gene in human cholangiocarcinoma cell line, J HEPATOL, 35(4), 2001, pp. 504-511

Authors: Caronia, S Bassendine, MF Barry, R Mills, P Naoumov, NV Fox, R Lowes, J Hollanders, D Murray-Lyon, L Irving, WL Goldin, RD Foster, GR
Citation: S. Caronia et al., Interferon plus amantadine versus interferon alone in the treatment of naive patients with chronic hepatitis C: a UK multicentre study, J HEPATOL, 35(4), 2001, pp. 512-516

Authors: Tabone, M Laudi, C Delmastro, B Biglino, A Andreoni, M Chieppa, F Bonardi, R Cariti, G Cusumano, S Brunello, F Calleri, G Manca, A Della Monica, P Sidoli, L Rizzetto, M Pera, A
Citation: M. Tabone et al., Interferon and amantadine in combination as initial treatment for chronic hepatitis C patients, J HEPATOL, 35(4), 2001, pp. 517-521

Authors: Stieger, B
Citation: B. Stieger, FIC1: another bile salt carrier within the enterohepatic circulation?, J HEPATOL, 35(4), 2001, pp. 522-524

Authors: Lee, SP Ko, CW
Citation: Sp. Lee et Cw. Ko, Pronucleating proteins in bile - a myth?, J HEPATOL, 35(4), 2001, pp. 525-526

Authors: Craxi, A Lo Iacono, O
Citation: A. Craxi et O. Lo Iacono, Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck?, J HEPATOL, 35(4), 2001, pp. 527-530

Authors: Bellentani, S Tiribelli, C
Citation: S. Bellentani et C. Tiribelli, The spectrum of liver disease in the general population: lesson from the Dionysos study, J HEPATOL, 35(4), 2001, pp. 531-537

Authors: Actis, GC Morgando, A Lagget, M David, E Rizzetto, M
Citation: Gc. Actis et al., Zafirlukast-related hepatitis: report of a further case, J HEPATOL, 35(4), 2001, pp. 539-541

Authors: Moles, JR Primo, J Fernandez, JM Hinojosa, JE
Citation: Jr. Moles et al., Acute hepatocellular injury associated with zafirlukast, J HEPATOL, 35(4), 2001, pp. 541-542

Authors: Dumortier, J Scoazec, JY Valette, PJ Ponchon, T Boillot, O
Citation: J. Dumortier et al., Successful liver transplantation for diffuse biliary papillomatosis, J HEPATOL, 35(4), 2001, pp. 542-543

Authors: Nishiguchi, S Shimoi, S Kurooka, H Tamori, A Habu, D Takeda, T Kubo, S
Citation: S. Nishiguchi et al., Randomized pilot trial of vitamin K-2 for bone loss in patients with primary biliary cirrhosis, J HEPATOL, 35(4), 2001, pp. 543-545

Authors: Menon, KVN Angulo, P Weston, S Dickson, ER Lindor, KD
Citation: Kvn. Menon et al., Bone disease in primary biliary cirrhosis: independent indicators and rateof progression, J HEPATOL, 35(3), 2001, pp. 316-323

Authors: Corpechot, C Benlian, P Barbu, V Chazouilleres, O Poupon, RE Poupon, R
Citation: C. Corpechot et al., Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis?, J HEPATOL, 35(3), 2001, pp. 324-328

Authors: Zietz, B Wengler, I Messmann, H Lock, G Scholmerich, J Straub, RH
Citation: B. Zietz et al., Early shifts of adrenal steroid synthesis before and after relief of short-term cholestasis, J HEPATOL, 35(3), 2001, pp. 329-337

Authors: Tang, TJ Batts, KP de Groen, PC van Hoek, B Haagsma, EB Hop, WCJ Janssen, HLA
Citation: Tj. Tang et al., The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome, J HEPATOL, 35(3), 2001, pp. 338-343

Authors: Guillygomarc'h, A Mendler, MH Moirand, R Laine, F Quentin, V David, V Brissot, P Deugnier, Y
Citation: A. Guillygomarc'H et al., Venesection therapy of insulin resistance-associated hepatic iron overload, J HEPATOL, 35(3), 2001, pp. 344-349

Authors: Barriere, E Tazi, KA Pessione, F Heller, J Poirel, O Lebrec, D Moreau, R
Citation: E. Barriere et al., Role of small-conductance Ca2+-dependent K+ channels in in vitro nitric oxide-mediated aortic hyporeactivity to alpha-adrenergic vasoconstriction in rats with cirrhosis, J HEPATOL, 35(3), 2001, pp. 350-357
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>